ArticleBone marrow transplantation2026

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

Sveva Castelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.